Suchergebnisse
Here's Why Park National (PRK) is a Great Momentum Stock to Buy
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Provident Financial (PFS) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Northwest Bancshares (NWBI) is a Great Momentum Stock: Should You Buy?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
WSFS Financial (WSFS) Is Up 0.45% in One Week: What You Should Know
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
CVNA Q2 Earnings Meet Estimates, Revenues Beat on Unit Growth
E-commerce used vehicle retailer Carvana CVNA reported earnings of 42 cents per share for the second quarter of 2026, in line with the Zacks Consensus Estimate. Earnings rose 61.5% year over year
Planet Fitness to Post Q2 Earnings: What's in the Cards for the Stock?
Planet Fitness, Inc. PLNT is scheduled to report second-quarter 2026 results on Aug. 6.PLNT’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise
Here is Why Growth Investors Should Buy Harmony Biosciences (HRMY) Now
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
3 Reasons Why Growth Investors Shouldn't Overlook Celestica (CLS)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to
QRVO Rises 11.6% in the Past Month: Can the Rally Continue?
Shares of Qorvo Inc. QRVO have rallied 11.6% over the past month as investors responded to improving profitability and signs that the company's strategic repositioning is gaining traction. The
Take-Two Set to Report Q1 Earnings: What's in the Cards for the Stock?
Take-Two Interactive Software TTWO is scheduled to report its first-quarter fiscal 2027 results on Aug. 7, 2026.For the first quarter of fiscal 2027, Take-Two expects GAAP net revenues between $1.45
Can Coca-Cola's Raised 2026 Outlook Support More Earnings Growth?
The Coca-Cola Company KO followed a better-than-expected second quarter by raising its fiscal 2026 outlook. Higher volume, margin expansion and currency benefits strengthened the earnings picture
Can FEMSA's Q2 Momentum Offset Margin Pressure Across Its Portfolio?
Fomento Económico Mexicano, S.A.B. de C.V. FMX, or FEMSA, topped second-quarter earnings and revenue expectations as OXXO Mexico and Coca-Cola FEMSA delivered solid growth. Net income and adjusted
Argan Acquires ValCor to Strengthen New England Presence
Argan, Inc. AGX has expanded its Teledata operations into New England through the acquisition of Connecticut-based ValCor Communications by its wholly owned subsidiary, Southern Maryland Cable Inc
Should Investors Buy ADTN or Wait for Better Execution Signals?
ADTRAN Holdings, Inc. ADTN continues to benefit from favorable long-term networking trends, but near-term execution challenges have made the investment case less straightforward. Investors must
Is Conagra Stock Worth Buying as Low Valuation Meets Weak Growth?
Conagra Brands, Inc. CAG presents a difficult value decision. The stock’s discounted forward earnings multiple offers a measure of downside support, but fiscal 2027 guidance points to lower sales
Large-cap Growth ETF (VOOG) Hits New 52-Week High
Vanguard S&P 500 Growth Index Fund ETF Shares VOOG is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 31.82% from its 52-week low price of
NewAmsterdam Pharma Maps Obicetrapib Strategy as PREVAIL Interim Nears
Key Points
- Interested in NewAmsterdam Pharma Company N.V.? Here are five stocks we like better.
- PREVAIL is the key near-term catalyst: NewAmsterdam expects to reach its interim event target by
Medline Q2 Earnings Call Highlights
Key Points
- Interested in Medline? Here are five stocks we like better.
- Medline reported strong second-quarter growth, with net sales up 12% to $7.7 billion, led by a 16% increase in Supply
Limbach Q2 Earnings Call Highlights
Key Points
- Interested in Limbach Holdings, Inc.? Here are five stocks we like better.
- Second-quarter profitability weakened despite revenue rising 22% to $173.5 million, as gross margin fell to
LivaNova Q2 Earnings Call Highlights
Key Points
- Interested in LivaNova PLC? Here are five stocks we like better.
- Record Q2 performance: Revenue rose 9.8% year over year on a constant-currency basis to $391 million, while adjusted


